Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

The relative duration and distance in each time gap. by Tomohiro Gonjo (8825780)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Summary results of the logistic regression model M2-12 including the significant two-way interactions to maximise loglikelihood. by Dennis Ochola (11626912)

Mean, SD, and Pearson correlations between SWB scales scores. by August Håkan Nilsson (12937056)

Subjects:

Predicted banana distribution map (2016) using logistic regression model M2-12 fitted using 12 covariates and significant two-way combinations. by Dennis Ochola (11626912)

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

<i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

Laser irradiation in the PBMT group. by Katayoon Montazeri (18389243)

Subjects:

Between-groups comparison of GIN and PPI values in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Diagram of methods. by Katayoon Montazeri (18389243)

Subjects:

Doublecortin (DCX) expression in 3 brain regions (coronal sections) in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

PBMT parameters. by Katayoon Montazeri (18389243)

Subjects:

Fig 4 - by Katayoon Montazeri (18389243)

Subjects:

Bar graphs of DCX expression evaluated in three brain regions in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

Between groups comparison of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Table_1_Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.xlsx by Guangyuan Zhang (538291)

“…Introduction<p>We aimed to investigate the feasibility of metabolomics to explain the underlying biological implications of radiomics features obtained from magnetic resonance imaging (MRI) preceding carbon ion radiotherapy (CIRT) in patients with prostate cancer and to further explore the clinical significance of radiomics features on the prognosis of patients, based on their biochemical recurrence (BCR) status.…”

Table_3_Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.docx by Guangyuan Zhang (538291)

“…Introduction<p>We aimed to investigate the feasibility of metabolomics to explain the underlying biological implications of radiomics features obtained from magnetic resonance imaging (MRI) preceding carbon ion radiotherapy (CIRT) in patients with prostate cancer and to further explore the clinical significance of radiomics features on the prognosis of patients, based on their biochemical recurrence (BCR) status.…”

Table_2_Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.docx by Guangyuan Zhang (538291)

“…Introduction<p>We aimed to investigate the feasibility of metabolomics to explain the underlying biological implications of radiomics features obtained from magnetic resonance imaging (MRI) preceding carbon ion radiotherapy (CIRT) in patients with prostate cancer and to further explore the clinical significance of radiomics features on the prognosis of patients, based on their biochemical recurrence (BCR) status.…”